COVID19 Outcomes in Older People - the COOP study
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.04301E+13
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
dr SP. prof MooijaartResearch Location
NetherlandsLead Research Institution
Leids Universitair Medisch CentrumResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Older adults (65 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
More than 90% of all deaths from COVID-19 occur in patients aged 70 years and older and functional decline is common. The elderly are very different in terms of vitality and vulnerability. Goal Customized treatment starts with a good assessment of the prognosis and knowledge about the disease, but much is still unknown. Does frailty predict the short- and long-term consequences of COVID-19 in older people? How do biological aging and vulnerability play a role in mortality or recovery? What are goals that are important for older people when making treatment decisions for acute serious conditions? Research design In the COOP study, all necessary professionals and elderly people work together to optimize the consequences of elderly people with COVID-19 through thorough scientific research. By using the many Dutch data previously collected in elderly people with COVID-19 in primary care, at home, in hospitals and in nursing homes, the results will become available quickly.